Neurological diseases affecting the central nervous system also tend to influence lower urinary function. Historically referred to as neurogenic bladder dysfunction, neurogenic lower urinary tract dysfunction (NLUTD) is affected by the nature of the underlying neurological disorder, the patient’s age and sex, and other factors. The role and clinical utility of urodynamic testing in NLUTD associated with Parkinson Disease, Multiple Sclerosis, Stroke and Alzheimer’s Disease and related dementias are presented.
Continuing Education Instructions and Disclosure Information:
Contact hours available until 10/31/23.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.
Faculty, Planners, and Speakers Conflict of Interest Disclosure:
Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.
Speakers Conflict of Interest Disclosure:
Mikel Gray, PhD, FNP, PNP, CUNP, CCCN, FAANP, FAAN – Consultant, Laborie Medical
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of NCPD does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
After completing this education activity, the learner will be able to describe the timing and approach when performing complex, multichannel urodynamic assessment of patients with NLUTD.